Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Interest & Investment Income: 2023-2024

Historic Interest & Investment Income for Artiva Biotherapeutics (ARTV) over the last 2 years, with Dec 2024 value amounting to $2.2 million.

  • Artiva Biotherapeutics' Interest & Investment Income rose 273.41% to $2.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.3 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is 111.01% up from last year.
  • As of Q4 2024, Artiva Biotherapeutics' Interest & Investment Income stood at $2.2 million, which was up 17.93% from $1.8 million recorded in Q3 2024.
  • Artiva Biotherapeutics' 5-year Interest & Investment Income high stood at $2.2 million for Q4 2024, and its period low was $418,000 during Q3 2023.
  • In the last 2 years, Artiva Biotherapeutics' Interest & Investment Income had a median value of $676,000 in 2024 and averaged $1.1 million.
  • The largest annual percentage gain for Artiva Biotherapeutics' Interest & Investment Income in the last 5 years was 341.63% (2024), contrasted with its biggest fall of 33.98% (2024).
  • Quarterly analysis of 2 years shows Artiva Biotherapeutics' Interest & Investment Income stood at $583,000 in 2023, then surged by 273.41% to $2.2 million in 2024.
  • Its Interest & Investment Income stands at $2.2 million for Q4 2024, versus $1.8 million for Q3 2024 and $676,000 for Q2 2024.